Phorbol ester augments butyrate-induced
✍
John A. McBain; Alan Eastman; David L. Simmons; George R. Pettit; Gerald C. Muel
📂
Article
📅
1996
🏛
John Wiley and Sons
🌐
French
⚖ 955 KB
Butyrate is a potentially selective therapeutic agent for many adenocarcinomas. Butyrate causes reversible growth arrest as well as some death of VACO 5 colon cancer cells. Combined treatment with butyrate and the phorbol ester TPA leads instead only to cell death, while TPA causes little death on i